Target intelligence / Profile preview

Yes-associated protein 1 (YAP) and Transcriptional coactivator with PDZ-binding motif (TAZ) (YAP1 (or YAP); TAZ (or WWTR1))

Target
YAP1 (or YAP); TAZ (or WWTR1)
Molecular classification
Transcriptional coactivator, Histone modification (through recruitment of p300 and PCAF), Transcription factor coregulator
01

Overview

YAP (Yes-associated protein 1) and TAZ (Transcriptional coactivator with PDZ-binding motif) are closely related transcriptional coactivators that function as downstream effectors of the Hippo tumor suppressor pathway.[1][2][3] These proteins lack intrinsic DNA-binding domains and instead regulate gene expression by physically associating with DNA-binding transcription factors, most notably the TEAD family of transcription factors (TEAD1-4), to activate genes involved in cell proliferation, growth, and survival.[1][2] Their activity is regulated by Hippo pathway signaling: when the pathway is active, YAP/TAZ are phosphorylated and sequestered in the cytoplasm; when inactive, they translocate to the nucleus to act as transcriptional coactivators.[1][2][3] YAP and TAZ are frequently overexpressed and oncogenic in multiple cancer types including breast, lung, ovarian, colorectal, and prostate cancers, where they promote malignant proliferation, invasion, metastasis, and chemotherapy resistance.[1][3] However, these proteins also possess context-dependent tumor-suppressive functions when bound to different partner transcription factors such as p73, whereby they can induce apoptosis in response to DNA damage.[1] Currently, there are no FDA-approved drugs specifically targeting YAP/TAZ, but disrupting their interaction with TEAD transcription factors represents an active therapeutic strategy under development.[5]

Other names
Yes-associated proteinYAP65YAP1Transcriptional coactivator with PDZ-binding motifWWTR1
02

Mechanism of action

Acts as a transcriptional coactivator by binding to DNA-binding transcription factors (primarily TEAD family members) to regulate target gene expression. Lacks intrinsic DNA-binding activity and requires partner transcription factors. Regulated by the Hippo pathway through phosphorylation and cytoplasmic sequestration. Competitive inhibition of TEAD/VGLL4 repressor complexes. Recruitment of SWI/SNF complexes and chromatin remodelers via partner proteins.

03

Biological functions

Gene transcription regulationCell proliferationCell growth and survivalApoptosis (context-dependent)Cell density sensingEMT (epithelial-mesenchymal transition) regulation
04

Disease associations

Cancer (breast, lung, ovarian, colorectal, prostate, multiple myeloma, non-small-cell lung cancer, gastric cancer)Tumorigenesis and oncogenic activityChemotherapy resistance (particularly in breast cancer)
05

Safety considerations

YAP1-knockout mice exhibit early embryonic lethality, indicating essential developmental rolesLiver-specific YAP overexpression leads to hepatomegaly and hepatocellular carcinoma, suggesting potential toxicity with systemic activationContext-dependent dual roles as both oncogene and tumor suppressor complicate therapeutic targeting
06

Biomarkers

High YAP/TAZ expression is associated with poor overall survival and disease-free survival in colorectal cancerHigh TAZ expression correlates with poor outcomes in breast, lung, and other cancersYAP1 and TAZ amplifications occur in squamous cell carcinomas (HNSC, CESC) in a mutually exclusive manner

Beyond the preview

Go deeper on Yes-associated protein 1 (YAP) and Transcriptional coactivator with PDZ-binding motif (TAZ) (YAP1 (or YAP); TAZ (or WWTR1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yes-associated protein 1 (YAP) and Transcriptional coactivator with PDZ-binding motif (TAZ) (YAP1 (or YAP); TAZ (or WWTR1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call